AstraZeneca Pharma

AstraZeneca Pharma

8,955.00
+61.50
(0.69%)
Market Cap
22,387.50 Cr
EPS
46.30
PE Ratio
126.95
Dividend Yield
0.36 %
Industry
Healthcare
52 Week High
10,691.00
52 Week Low
6,220.00
PB Ratio
28.86
Debt to Equity
0.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
AstraZeneca Pharma India has issued a clarification stating that it is not involved in US pricing news. The company has denied any material impact on its operations and stated there is no regulatory action affecting it.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,642.70
#1 3,94,138.76
34.07
#1 54,729.00
9.71
#1 10,980
-19.84
36.52
6,507.00
1,72,740.41
77.07
9,712.00
0.89
2,191
23.05
30.87
3,624.50
1,22,669.55
61.58
11,539.40
6.99
1,911
19.91
66.62
1,517.10
1,22,537.35
22.49
28,409.50
7.12
5,291
9.88
48.02
2,614.90
1,07,924.44
55.95
12,744.20
#1 20.90
2,007
-18.14
54.69
1,229.10
1,02,577.13
#1 17.92
33,741.20
16.73
5,725
1.26
35.90
958.80
96,477.71
20.54
23,511.00
13.82
4,615
-0.19
40.50
1,878.90
85,808.51
26.24
22,909.50
19.94
3,306
#1 112.49
37.22
33,890.00
72,013.88
50.58
6,684.70
10.80
1,414
27.83
48.05
1,097.60
63,748.79
18.15
31,378.10
17.55
3,366
-0.50
36.97
Forecast
Actual
Growth Rate
Revenue Growth
29.27 %
Net Income Growth
62.64 %
Cash Flow Change
134.52 %
ROE
34.50 %
ROCE
36.57 %
EBITDA Margin (Avg.)
-11.30 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
523
571
558
583
745
845
826
820
1,029
1,330
1,757
Expenses
529
547
507
525
657
711
678
719
838
1,111
1,462
EBITDA
-6
23
51
59
88
134
148
101
191
219
295
Operating Profit %
-2 %
3 %
7 %
8 %
10 %
15 %
17 %
11 %
16 %
14 %
15 %
Depreciation
15
17
16
15
15
19
20
17
16
15
40
Interest
0
0
0
0
0
1
1
1
1
1
2
Profit Before Tax
-21
6
36
44
73
114
127
83
134
220
156
Tax
0
1
15
18
18
42
34
21
35
58
41
Net Profit
-21
5
20
26
54
72
93
62
99
162
116
EPS in ₹
-8.34
2.10
8.00
10.40
21.80
28.90
37.30
24.60
39.70
64.60
46.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
412
403
416
461
562
706
775
857
985
1,078
1,518
Fixed Assets
101
97
87
76
75
72
81
75
69
67
64
Current Assets
263
267
252
321
405
542
619
706
836
933
1,342
Capital Work in Progress
12
6
5
4
7
24
4
2
1
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
298
299
324
382
480
611
690
780
915
1,011
1,454
Total Liabilities
412
403
416
461
562
706
775
857
985
1,078
1,518
Current Liabilities
260
234
190
207
259
327
304
333
384
357
703
Non Current Liabilities
1
13
2
7
2
15
15
13
12
9
45
Total Equity
151
156
223
247
301
364
456
511
589
712
770
Reserve & Surplus
146
151
218
242
296
359
451
506
584
707
765
Share Capital
5
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-64
53
38
-1
59
-90
269
96
52
5
31
Investing Activities
-19
-4
0
-9
4
-171
173
5
18
22
31
Operating Activities
-46
57
38
9
55
87
105
101
58
28
65
Financing Activities
0
-1
0
0
0
-6
-9
-10
-25
-44
-66

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.69 %
0.00 %
2.74 %
2.79 %
2.90 %
2.93 %
2.89 %
3.03 %
DIIs
0.83 %
0.94 %
0.96 %
1.00 %
1.02 %
1.10 %
1.12 %
1.44 %
1.42 %
1.93 %
2.43 %
2.75 %
3.78 %
5.01 %
5.10 %
5.22 %
4.65 %
4.56 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.53 %
19.72 %
19.69 %
19.44 %
19.06 %
18.62 %
18.54 %
18.56 %
18.46 %
18.12 %
17.44 %
17.09 %
16.33 %
15.00 %
14.77 %
14.62 %
15.16 %
15.18 %
Others
4.64 %
4.34 %
4.34 %
4.57 %
4.92 %
5.28 %
5.34 %
5.01 %
5.12 %
4.95 %
2.44 %
5.15 %
2.15 %
2.20 %
2.23 %
2.24 %
2.31 %
2.23 %
No of Share Holders
0
63,753
68,077
66,444
62,183
57,760
53,980
49,085
42,146
38,946
32,380
29,032
29,418
27,169
27,615
27,322
32,466
34,378

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 1 2 10 16 24 32
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.03 0.08 0.31 0.3 0.28 0.36

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 8,953.35 8,893.50
14 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
14 Aug 2025 8,832.65 8,893.50
18 Jul 2025 DIVIDEND Dividend
₹ 32.00 /share
18 Jul 2025 7,918.50 9,386.25
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 7,920.85 7,918.50
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 6,920.30 7,535.10
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 7,155.25 7,410.50
08 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Aug 2024 6,610.75 7,090.80
05 Jul 2024 DIVIDEND Dividend
₹ 24.00 /share
05 Jul 2024 6,011.75 7,120.15
14 Jul 2023 DIVIDEND Dividend
₹ 16.00 /share
14 Jul 2023 3,253.00 3,767.35
08 Aug 2022 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Aug 2022 2,982.60 3,079.00
08 Jul 2022 DIVIDEND Dividend
₹ 8.00 /share
07 Jul 2022 2,635.15 2,898.90
20 Aug 2021 DIVIDEND Dividend
₹ 2.00 /share
18 Aug 2021 3,406.35 3,101.65

Announcements

Clarification On News Item Appearing In Https://Www.Moneycontrol.Com2 days ago
Clarification sought from AstraZeneca Pharma India Ltd2 days ago
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday August 14 202510 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Business Responsibility and Sustainability Reporting (BRSR)Jul 22, 2025
Notice Of 46Th Annual General MeetingJul 22, 2025
Reg. 34 (1) Annual Report.Jul 22, 2025
Communication To The Shareholders W.R.T. TDS On DividendJul 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 16, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jul 14, 2025
Disclosure under Regulation 30A of LODRJul 11, 2025
Record Date For Payment Of Final DividendJul 11, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jul 01, 2025
Determination Of Materiality - Details Of Key Managerial PersonnelJul 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jun 20, 2025
Closure of Trading WindowJun 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2025
Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorJun 09, 2025
Disclosure under Regulation 30A of LODRJun 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Secretarial AuditorMay 30, 2025
Outcome Of The Board Meeting Held On Friday May 30 2025 May 30, 2025
Board Meeting Outcome for Recommendation Of Dividend For The Financial Year 2024-25May 30, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015May 30, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015May 29, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Friday May 30 2025May 21, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015May 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018May 08, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Apr 15, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Apr 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 04, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 28, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Mar 28, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 22, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 19, 2025
Closure of Trading WindowMar 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Mar 14, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Mar 07, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Mar 06, 2025
Integrated Filing (Financial)Mar 03, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Mar 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 25, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management PersonnelFeb 25, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Outcome Of The Board Meeting Held On Tuesday February 11 2025Feb 11, 2025

Technical Indicators

RSI(14)
Neutral
45.06
ATR(14)
Volatile
273.44
STOCH(9,6)
Neutral
34.07
STOCH RSI(14)
Neutral
58.22
MACD(12,26)
Bearish
-8.64
ADX(14)
Weak Trend
21.49
UO(9)
Bearish
43.44
ROC(12)
Downtrend And Accelerating
-2.91
WillR(14)
Oversold
-91.43

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Small Cap Fund Direct-Growth
0.00%
-14422
-0.10%
-0.12%
Samco Active Momentum Fund Direct - Growth
3.30%
11953
1.36%
1.19%
ICICI Prudential Smallcap Fund Direct Plan-Growth
0.04%
-11145
-0.11%
-0.37%
ICICI Prudential ESG Exclusionary Strategy Fund Direct - Growth
0.47%
8213
0.47%
0.47%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.71%
5000
0.71%
0.71%
Bandhan Large Cap Fund Direct-Growth
0.22%
4682
0.22%
0.22%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.91%
3709
0.91%
0.91%
ICICI Prudential Retirement Fund - Pure Equity Plan Direct - Growth
0.15%
2167
0.15%
0.15%
Bandhan Innovation Fund Direct-Growth
3.70%
-2100
0.06%
-0.35%
Motilal Oswal Quant Fund Direct-Growth
0.92%
1528
0.92%
0.92%
Nippon India Pharma Fund Direct-Growth
0.65%
-1510
0.04%
-0.02%
ICICI Prudential Midcap Direct Plan-Growth
0.01%
606
0.01%
0.01%
Bajaj Finserv Healthcare Fund Direct-Growth
1.32%
392
0.19%
0.05%
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth
0.34%
-377
-0.12%
-0.20%
DSP Nifty Smallcap250 Quality 50 Index Fund Direct - Growth
1.64%
272
0.11%
-0.20%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
193
0.01%
-0.04%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
129
0.03%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
1.40%
87
0.04%
-0.15%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.27%
83
0.01%
-0.04%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
43
0.01%
-0.04%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
38
0.01%
-0.04%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth
0.80%
23
0.00%
-0.16%
UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund Direct-Growth
0.32%
19
-0.03%
-0.09%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.07%
-15
0.00%
-0.01%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
11
0.01%
-0.04%

About AstraZeneca Pharma

AstraZeneca Pharma India Limited is a biopharmaceutical company incorporated in 1979. It manufactures, distributes, and markets pharmaceutical products, focusing on cardiovascular, renal and metabolism, oncology, and respiratory diseases. The company operates in the healthcare segment and provides clinical trial services to an overseas group company. Key products include Forxiga for heart failure and chronic kidney disease, Imfinzi for biliary tract carcinoma, Lynparza for breast cancer, and oral antidiabetic drugs like Onglyza and Kombiglyze. AstraZeneca Pharma India is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is indirectly owned by AstraZeneca PLC, United Kingdom. The company has manufacturing facilities in Bangalore and has expanded its R&D presence in India.
Chairperson NameShilpa Divekar Nirula